Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)
55.75
-2.55 (-4.37%)
Apr 3, 2025, 4:08 PM HKT
HKG:6821 Revenue
In the year 2024, Asymchem Laboratories (Tianjin) had annual revenue of 5.80B CNY, down -25.82%. Asymchem Laboratories (Tianjin) had revenue of 1.66B in the quarter ending December 31, 2024, with 15.41% growth.
Revenue
5.80B CNY
Revenue Growth
-25.82%
P/S Ratio
n/a
Revenue / Employee
593.04K CNY
Employees
9,788
Market Cap
28.71B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.80B | -2.02B | -25.82% |
Dec 31, 2023 | 7.83B | -2.43B | -23.70% |
Jan 1, 2023 | 10.26B | 5.62B | 121.40% |
Dec 31, 2021 | 4.63B | 1.50B | 47.67% |
Dec 31, 2020 | 3.14B | 676.74M | 27.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
WuXi Biologics | 19.87B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |